Chimerix, Inc.
CMRXNASDAQHealthcare
$8.54
+$0.00(+0.00%)
Market Cap$801084452
P/E Ratio—
52W High$8.55
52W Low$0.75
Chimerix, Inc. (CMRX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CMRX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.21M | $0.32M | $33.82M | $1.98M | $5.37M |
| Cost of Revenue | $0.00M | $0.00M | $0.45M | $0.47M | $36.23M |
| Gross Profit | $0.21M | $0.32M | $33.38M | $1.51M | ($30.86M) |
| Gross Margin %(computed) | 100.00% | 100.00% | 98.68% | 76.35% | -574.46% |
| Operating Expenses | |||||
| R&D Expenses | $74.57M | $68.79M | $71.63M | $73.82M | $36.23M |
| G&A Expenses | $22.20M | $24.60M | $22.13M | $18.67M | $13.66M |
| Total Operating Expenses | $96.78M | $93.39M | $93.76M | $92.49M | $49.89M |
| Operating Income | ($96.57M) | ($93.06M) | ($60.39M) | ($173.40M) | ($44.52M) |
| Operating Margin %(computed) | — | — | -178.53% | — | -828.67% |
| Interest Income | $8.18M | $10.97M | $2.92M | $0.16M | $0.99M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($88.39M) | ($82.09M) | $172.20M | ($173.24M) | ($43.52M) |
| Income Tax Expense | $0.00M | $0.00M | $0.04M | $0.00M | $0.00M |
| Net Income | ($88.39M) | ($82.09M) | $172.17M | ($255.79M) | ($42.13M) |
| Net Margin %(computed) | — | — | 509.01% | — | -784.18% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.99 | $-0.93 | $1.97 | $-3.01 | $-0.68 |
| Wtd Avg Shares | 89.70M | 88.60M | 87.56M | 84.93M | 62.18M |
| EBITDA | ($96.47M) | ($92.97M) | ($60.28M) | ($90.34M) | ($44.11M) |
| EBITDA Margin %(computed) | — | — | -178.21% | — | -821.18% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Chimerix, Inc. data
About Chimerix, Inc. (CMRX) Income Statement
Chimerix, Inc. (CMRX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, CMRX reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.09B) — a net profit margin of -41691.98%.
Frequently asked questions
CMRX · 4 questionsChimerix, Inc. (CMRX) reported revenue of $0.00B for 2024, down 34.6% year-over-year.
CMRX revenueCMRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09